Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 in the page header, indicating a small platform update to ClinicalTrials.gov. This change does not alter study details or other visible content.
    Difference
    0.1%
    Check dated 2026-07-03T22:58:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a small patch to the page or underlying system. No study data or navigation elements appear to be modified.
    Difference
    0.1%
    Check dated 2026-06-27T01:49:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The primary condition label 'Multiple myeloma' and the related topics section (including MedlinePlus Genetics) were removed from the page. This changes what the page presents about the study’s condition and the available educational links.
    Difference
    0.2%
    Check dated 2026-06-19T23:52:37.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also shows that recruitment is closed ('No longer looking for participants') and updates the revision version to v3.6.0 (replacing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-12T17:24:29.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page now references Multiple myeloma as a study context and includes a related topics link to MedlinePlus Genetics, enriching the study's topical scope and external resources. The metadata revision was updated to v3.5.5 (replacing v3.5.4).
    Difference
    0.2%
    Check dated 2026-06-05T17:42:53.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    New revision label Revision: v3.5.4 was added. An older revision (v3.5.3) and several topic references, including Multiple myeloma and MedlinePlus Genetics, were removed.
    Difference
    0.2%
    Check dated 2026-05-15T06:14:15.000Z thumbnail image

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.